Teladoc Health Inc (TDOC)
Industry Health Information Services
This stock can be held in an Investment ISA and an Investment Account
Sell
$7.34
Buy
$7.42
$0.03 (+0.42%)
Teladoc Inc provides telehealth platform, delivering on-demand healthcare anytime, anywhere, via mobile devices, the internet, video and phone.
Prices updated at 09 May 2025, 11:00 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
233m | 418m | 553m | 1,094m | 2,033m | 2,407m | 2,602m | 2,570m | |
172m | 289m | 369m | 703m | 1,382m | 1,663m | 1,842m | 1,818m | |
-62m | -66m | -74m | -418m | -239m | -227m | -211m | -209m | |
-26.66 | -15.78 | -13.34 | -38.23 | -11.76 | -9.45 | -8.09 | -8.13 | |
-107m | -97m | -99m | -485m | -429m | -13,660m | -220m | -1,001m | |
-70m | -35m | -35m | -438m | -84m | -13,374m | 151m | -587m | |
Sales, General and administrative | 180m | 265m | 339m | 887m | 1,105m | 1,301m | 1,367m | 1,346m |
Interest expenses | 17m | 26m | 29m | 60m | 81m | 22m | 22m | 24m |
Provision for income taxes | -225,000 | 118,000 | -11m | -91m | 44m | -4m | 760,000 | 8m |
Operating expenses | 234m | 355m | 443m | 1,121m | 1,621m | 1,890m | 2,053m | 2,027m |
Income before taxes | -107m | -97m | -109m | -576m | -385m | -13,663m | -220m | -994m |
Net income available to common shareholders | -107m | -97m | -99m | -485m | -429m | -13,660m | -220m | -1,001m |
-1.93 | -1.47 | -1.38 | -5.36 | -2.73 | -84.6 | -1.34 | -5.87 | |
Net interest income | -17m | -26m | -29m | -60m | -80m | -9m | 25m | 33m |
Advertising and promotion | - | - | - | - | - | - | - | - |
Net investment income, net | - | - | - | - | - | - | - | - |
Realised capital gains (losses), net | - | - | - | - | - | - | - | - |
Total benefits, claims and expenses | - | - | - | - | - | - | - | - |
Earnings per share (diluted) | -1.93 | -1.47 | -1.38 | -5.36 | -2.73 | -84.6 | -1.34 | -5.87 |
Free cash flow per share | -0.756 | -0.3515 | 0.0533 | 0.7681 | -0.361 | 0.4049 | 0.6831 | 1.2253 |
Book value/share | 7.2607 | 14.575 | 13.6574 | 14.8458 | 99.6301 | 37.1693 | 13.765 | 8.6947 |
Debt equity ratio | 0.37103 | 0.409313 | 0.458967 | 0.089571 | 0.078989 | 0.681761 | 0.679912 | 0.686451 |
Balance sheet
Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current assets | 156m | 533m | 588m | 1,060m | 1,225m | 1,315m | 1,489m | 1,664m |
Current liabilities | 40m | 62m | 90m | 333m | 331m | 400m | 421m | 942m |
Total capital | 766m | 1,428m | 1,454m | 17,263m | 17,271m | 3,843m | 3,865m | 2,482m |
Total debt | 207m | 415m | 470m | 1,477m | 1,280m | 1,587m | 1,592m | 1,585m |
Total equity | 559m | 1,013m | 1,014m | 15,884m | 16,046m | 2,308m | 2,326m | 1,491m |
Total non current liabilities | - | - | - | - | - | - | - | - |
Loans | 207m | 415m | 440m | 1,380m | 1,226m | 1,535m | 1,539m | 991m |
Total assets | 824m | 1,529m | 1,603m | 17,755m | 17,735m | 4,345m | 4,392m | 3,517m |
Total liabilities | - | - | - | - | - | - | - | - |
Cash and cash equivalents | 43m | 424m | 514m | 733m | 893m | 918m | 1,124m | 1,298m |
Common stock | 62m | 71m | 73m | 150m | 160m | 163m | 167m | 173m |
Cash flow
Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 50m | 43m | 424m | 514m | 733m | 893m | 918m | 1,124m |
Cash dividends paid | - | - | - | - | - | - | - | - |
-40m | -13m | 19m | -80m | 130m | 17m | 194m | 170m | |
Investments (gains) losses | -448m | -257m | 25m | -591m | -73m | -168m | -156m | -124m |
43m | 424m | 514m | 733m | 893m | 918m | 1,124m | 1,298m | |
Net income | - | - | - | - | - | - | - | - |
-34m | -5m | 30m | -54m | 194m | 189m | 350m | 294m | |
-6m | -8m | -11m | -26m | -64m | -173m | -156m | -124m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.